Goldman Sachs analysts led by Steven Kron share the firm's latest conviction list, which includes 23 of the bank's top picks ...

The housing market remains constrained in 2025. Goldman said mortgage rates will stay elevated, raising its year-end target ...

Goldman Sachs has reined in risk-taking due to market volatility triggered by Donald Trump’s trade war and fears that rising ...

Fintel reports that on June 6, 2025, Goldman Sachs upgraded their outlook for MasTec (NYSE:MTZ) from Neutral to Buy. Analyst ...

Goldman Sachs has moderated its risk-taking since U.S. President Donald Trump's April tariff announcement, and the Wall ...

Goldman Sachs has added these three stocks to its Conviction List. They all have at least 20% upside potential to the analyst ...

Goldman Sachs initiated coverage on U.S.-listed generic pharmaceutical companies with Buy ratings on Teva Pharmaceutical Industries (NYSE:TEVA) and Amneal Pharmaceuticals (NASDAQ:AMRX), and a Neutral ...

Goldman Sachs lowered Tesla's target price citing weak deliveries in Europe and US. Tesla stock fell 14% on Thursday, wiping ...

Hedge funds bought global equities last week at the quickest pace since November 2024, Goldman Sachs said in a note, just as ...

Adamolekun, 36, took over as CEO of Red Lobster in September, as the seafood chain was crawling from the ashes of bankruptcy.

On Thursday, Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC: BAYRY) to Buy from Neutral, while ...